In a previous study, we showed that follicle size at weaning affects the response of a sow to a short-term altrenogest treatment after weaning. In this study, an attempt was made to prevent the growth of follicles into larger size categories before weaning by using different altrenogest treatments before weaning to improve reproductive performance after postweaning altrenogest treatments. Sows (87 primiparous and 130 multiparous) were assigned to the following treatments: control (no altrenogest treatment; n = 59), RU0-20 (20 mg of altrenogest from d −1 to 6; weaning = d 0; n = 53), RU40-20 (40 mg of altrenogest from d −3 to 0 and 20 mg of altrenogest from d 1 to 6; n = 53), and RU20-20 (20 mg of altrenogest from d −3 to 6; n = 52). Follicle size was assessed daily with transabdominal ultrasound. Follicle sizes on d −3 (3.6 ± 0.7 mm) and at weaning (4.0 ± 0.7 mm) were similar for all treatments. Altrenogest-treated sows had larger follicles at the beginning of the follicular phase than did control sows [5.4 ± 0.1 and 3.8 ± 0.2 mm (least squares means), respectively; P < 0.0001] and on d 4 of the follicular phase [8.0 ± 0.1 and 6.7 ± 0.2 mm (least squares means), respectively; P < 0.0001]. Multiparous sows had larger follicles than did primiparous sows at the beginning of the follicular phase [5.3 ± 0.1 and 4.7 ± 0.1 mm (least squares means), respectively; P < 0.01] and on d 4 of the follicular phase [8.0 ± 0.1 and 7.0 ± 0.1 mm (least squares means), respectively; P < 0.0001]. Farrowing rate and litter size (born alive + dead) were not affected by treatment or parity. However, in primiparous sows, when mummies were included in litter size, altrenogest-treated sows had larger litters than did control sows (13.4 ± 0.5 and 11.9 ± 0.7 piglets, respectively; P = 0.02). In primiparous control sows, backfat depth at weaning and litter size were positively related (slope of the regression line = 0.82; P < 0.05), which was not the case in primiparous sows receiving altrenogest. In conclusion, the different altrenogest treatments before weaning did not prevent the growth of follicles before weaning and similarly affected subsequent follicle development and fertility. In primiparous sows, altrenogest treatment after weaning increased the number of fetuses during pregnancy, but positive effects seemed limited by uterine capacity. Altrenogest treatment after weaning improved litter size in primiparous sows with reduced backfat depth at weaning, which suggests a specific positive effect of a recovery period after weaning in sows with reduced BCS at weaning.
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INTRODUCTION
Reduced reproductive performance in the second litter as a result of a negative energy balance during first lactation can be prevented by altrenogest treatments after weaning. Several studies, differing in the timing, duration, and dose of altrenogest treatments, have found greater ovulation rates (Koutsotheodoros et al., 1998; Patterson et al., 2008) , better synchronization of estrus (Martinat-Botté et al., 1994; MartinatBotté, 1995) , improved embryo survival (Patterson et al., 2008) , and greater litter sizes (Martinat-Botté et al., 1990; van Leeuwen et al., 2010) for primiparous sows treated with altrenogest after weaning.
The positive effect of altrenogest treatment after weaning on subsequent reproductive performance seems dependent on the duration of treatment in relation to follicular status at weaning. van Leeuwen et al. (2011) found that a postweaning altrenogest treatment for 15 consecutive days resulted in improved reproductive performance (increased farrowing rate and litter size) regardless of follicular status at weaning, but shorter term postweaning altrenogest treatments (4 or 8 d) were beneficial only for sows with small follicles at weaning, and they adversely affected fertility in sows with large follicles at weaning. It was hypothesized that these adverse effects were caused by "aging" of the larger follicles that failed to go into atresia during short altrenogest treatments (van Leeuwen et al., 2011) .
Therefore, this study used altrenogest treatments of different doses before weaning in an attempt to prevent the growth of follicles before weaning, and it investigated the consequences on reproductive performance after subsequent postweaning altrenogest treatments.
MATERIALS AND METHODS
The study was conducted during spring, from September 2009 to December 2009 in a commercial swine herd in Monte Buey, Argentina (32°25′00″ S, 62°27′00″ W). All animal procedures followed the Argentine animal welfare law (Ley penal 14346).
Animals, Housing, and Diets
Pregnant sows (n = 217; Line PIC23) entered the maternity facilities at 2 to 6 d before farrowing, at approximately 319 to 323 d of age, with an average BW of 246 ± 29 kg. On d 114 of gestation, all sows received 75 μg intramuscularly of a PGF 2α analog (D cloprostenol, Bioprost, Biotay, Buenos Aires, Argentina). At farrowing, the numbers of piglets born alive or dead were recorded, and the total weight of piglets born alive and dead was assessed. Litter size (total born) averaged 12.6 ± 2.7 piglets. Postpartum cross-fostering was performed within 3 d to adjust litter size to 11 to 13 piglets. During lactation, sows were fed a corn-and soybean-based diet, formulated to contain 14.48 MJ of DE/kg with 18% CP and 1% lysine, to appetite, to a maximum of 8 kg/d. On d 21 (d 19 to 23) of lactation, piglets were weaned (10.8 ± 1.1 piglets/sow) and sows were moved to individual crates in another barn and fed once each day (0700 h) to a maximum of 4 kg of a corn-and soybean-based diet formulated to contain 13.65 MJ/kg with 14% CP and 1% lysine. All crates were equipped with individual drinking nipples providing water ad libitum.
Daily minimum and maximum environmental temperatures were registered throughout the experiment. Average temperature varied between a maximum of 20.0 ± 5°C and a minimum of 6.6 ± 4°C in September and a maximum of 27.7 ± 3°C and a minimum of 17 ± 3°C in December. When the environmental temperature (outside the barn) exceeded 28°C, spray coolers were activated in the gestation barn.
Sows were weighed and P2 backfat depth was measured using A-mode ultrasound (Lean-Meater, Renco Corporation, Minneapolis, MN) when the sows entered the farrowing facilities, at weaning, and for altrenogesttreated sows on the day after the last altrenogest treatment. Farrowing weight was corrected for weight of the litter at birth + estimated placental weight, for amnion weight (216 g/fetus), and for estimated fetal growth during the time between weighing and farrowing (60 g/fetus per day) based on the methods of Leenhouwers et al. (2002) and van Rens et al. (2002 van Rens et al. ( , 2005 . The corrected farrowing weight averaged 227 ± 28 kg, and backfat depth at farrowing was 18.0 ± 7 mm. 
Treatments

Estrus Detection and Insemination
From weaning onward, estrous detection was performed daily at 1030 h by a trained farm technician using fence-line boar contact. Estrus was considered to begin when a sow first exhibited a standing reflex during a back pressure test in the presence of a boar and to end when a sow first failed to exhibit a standing reflex. Sows were artificially inseminated in the afternoon after the first detected estrus (1400 h), and inseminations were repeated the next morning at 0830 h, if the sow still exhibited a good standing reflex. Inseminations consisted of a 100-mL dose of semen that was obtained from the boars on the farm (PIC 415), with a dosage of 4 × 10 9 sperm cells. Merck III (Mini Tüb, Tiefenbach, Germany) was used as an extender. Semen was stored at 17°C for a maximum of 3 d.
Follicular Development and Reproductive Performance
Transabdominal ultrasound with a 5-MHz multiconvex transducer (Aquila, Piemedical, Maastricht, the Netherlands) was performed to assess follicular devel-opment. One ovary was scanned each time because it was considered representative of the contralateral ovary (N. M. Soede, unpublished results). Recorded images were subsequently reviewed using the cineloop application of the scanner. The diameters of the 5 largest follicles were measured and averaged. Follicular development was assessed on d −3 for sows in the control, RU40-20, and RU20-20 treatments, at d 0 (weaning) for all sows, 1 d after the last altrenogest treatment for altrenogest-treated sows, and on d 4 of the follicular phase for all sows. The onset of the follicular phase was assumed to begin at weaning for control animals and at 1 d after the last altrenogest administration for altrenogest-treated animals (van Leeuwen et al., 2010 Leeuwen et al., , 2011 .
On d 114 of gestation, pregnant sows received 75 μg intramuscularly of a PGF 2α analog (D cloprostenol, Bioprost). At farrowing, piglets were weighed and the numbers of piglets born alive or dead were recorded, and placentas were thoroughly checked for (hidden) mummies, after which the total number of mummies was recorded.
Statistical Analyses
Data were analyzed using SAS (SAS Inst. Inc., Cary, NC). Sows that failed to show estrus within 10 d after weaning (4 out of 59 control sows) or 11 d after the last altrenogest treatment (4 out of 158 altrenogest-treated sows) were marked as not showing estrus, and their follicular development and subsequent reproductive performance were not included in the analyses. Normality of the model residuals was checked with the UNIVARI-ATE procedure of SAS. The normally distributed parameters were analyzed with the GLM procedure of SAS, with treatment + parity class as the main effects plus their interaction (model 1). When the interaction was not significant, it was omitted from the model. Whenever the main effects were significant, means were compared by the LSD method with Bonferroni correction for multiple comparisons.
Because none of the reproductive performance variables differed among the 3 altrenogest treatments, analyses for treatment effects on subsequent fertility were also performed on pooled data from all altrenogest-treated sows vs. control sows.
To study the effects of lactational burden with follicular development and litter size, model 1 was extended with backfat depth at weaning, backfat depth loss, BW at weaning, or BW loss during lactation, and their interactions with treatment or parity (model 2).
Follicular development was further analyzed with the GLM procedure of SAS using repeated measures. The GLM model included treatment, parity (primiparous or multiparous), sow within treatment × parity, and day of the follicular phase (beginning of follicular phase = d 0 for control sows and d 7 for altrenogest-treated animals, or the fourth day of the follicular phase). Differences in follicle size between treatments and between parities were tested against the error term of sow within treatment × parity, and differences in follicle size between days of the follicular phase were tested against the overall error term. The interaction between treatment and day of the follicular phase and between treatment and parity were not significant and therefore were omitted from the model. Treatment effects on estrous rate (percentage of sows showing estrus within 10 d from weaning or 11 d from the last altrenogest treatment) and farrowing rate were analyzed using the FREQUENCY procedure of SAS with Fisher's exact test. Synchrony of estrus was expressed as the percentage of sows in estrus within a 48-h period. For primiparous sows (control and altrenogesttreated sows), the 48-h time window covered d 4 to 5 after the beginning of the follicular phase. For multiparous altrenogest-treated and control sows, respectively, the tightness of synchronization was measured on d 3 to 4 or d 4 to 5 after the beginning of the follicular phase.
A probability level of <0.05 was considered significant, and P < 0.1 was considered a tendency. Data presented in the text are means ± SD unless stated otherwise, and data presented in the tables are least squares means ± SE.
RESULTS
Lactation, BW Loss, and Backfat Depth Loss
From 20.6 ± 1.6 d of lactation, sows lost on average 19.3 ± 17.6 kg of BW. This was 8.3 ± 7.6% of their BW and 3.7 ± 2.1 mm of backfat depth, which was similar for all treatments. Primiparous sows differed from multiparous sows in farrowing weight [203 ± 2 and 243 ± 2 kg (least squares means), respectively; P < 0.0001] and number of piglets weaned [10.6 ± 0.1 and 11.0 ± 0.1 piglets (least squares means); P < 0.008], and tended to have lost less backfat depth [3.4 ± 0.2 and 3.9 ± 0.2 mm (least squares means), respectively; P < 0.06].
Follicular Development
Two sows showed abnormal follicular development, and their data were excluded from the analyses of follicular development: 1 primiparous sow in the RU20-20 treatment had a follicle size of 16 mm at weaning and 9 mm at the beginning of the follicular phase. This sow showed estrus and subsequently delivered 15 piglets. One multiparous sow in the RU0-20 treatment had a follicle size of 19 mm at d 4 of the follicular phase, showed estrus, but was not pregnant on d 30.
Follicle sizes on d −3 were similar for sows in the control, RU40-20, and RU20-20 treatments (on average 3.6 ± 0.7 mm) and were not affected by parity (Table  1) . From d −3 until weaning, follicles grew on average 0.5 ± 0.9 mm (0.15 ± 0.3 mm/d), which resulted in an average follicle size at weaning of 4.0 ± 0.7 mm.
Follicular growth rate between d −3 and 0 was less in primiparous than in multiparous sows (0.05 ± 0.06 and 0.21 ± 0.04 mm/d, respectively; P = 0.03). Follicle size at weaning was similar among treatments, but primiparous sows had smaller follicles at weaning than did multiparous sows (3.8 ± 0.1 and 4.1 ± 0.1 mm, respectively; P = 0.004; Figure 1 ). During the altrenogest treatment, follicles grew 1.6 ± 2.1 mm, resulting in larger follicles at the beginning of the follicular phase for altrenogest-treated animals compared with control animals (5.4 ± 0.2, 5.3 ± 0.2, 5.3 ± 0.2, and 3.9 ± 0.2 mm, for the RU0-20, RU40-20, RU20-20, and control treatments, respectively; P < 0.0001; Table 1 and Figure 1) . Overall, follicle size was smaller at the beginning of the follicular phase than on d 4 of the follicular phase (4.9 ± 0.1 and 7.7 ± 0.1 mm, respectively; P < 0.0001), was smaller in control sows than in altrenogest-treated sows (5.3 ± 0.1, 6.7 ± 0.2, 6.5 ± 0.2, and 6.6 ± 0.2 mm for the control, RU0-20, RU40-20, and RU20-20 treatments, respectively; P < 0.0001), and was smaller in primiparous sows than in multiparous sows (5.9 ± 0.1 and 6.7 ± 0.1 mm, respectively; P < 0.0001); no significant interactions were observed among day, treatment, and parity. When comparing the pooled data of altrenogest-treated sows with control sows, follicle size at the beginning of the follicular phase was larger for altrenogest-treated sows than for control sows (5.4 ± 0.1 and 3.8 ± 0.2 mm, respectively; P < 0.0001). On d 4 of the follicular phase, average follicle size was still larger for altrenogest-treated sows compared with control sows (8.0 ± 0.1 and 6.7 ± 0.2 mm, respectively; P < 0.0001), and was similar for all altrenogest treatments (8.0 ± 0.2, 7.7 ± 0.2, and 7.7 ± 0.2 mm, for the RU0-20, RU40-20, and RU20-20 treatments, respectively; P = 0.4). The follicular growth pattern was similar among parities, but primiparous sows had smaller follicles than did multiparous sows at the beginning of the follicular phase (4.7 ± 0.1 and 5.3 ± 0.1 mm, respectively; P = 0.009) and on d 4 of the follicular phase (7.0 ± 0.1 and 8.0 ± 0.1 mm, respectively; P < 0.0001, Figure 1 
Estrus, Farrowing Rate, and Litter Size
On average, 96% of the sows showed estrus within 10 d after the beginning of the follicular phase. In primiparous sows, this percentage was less in control sows than in altrenogest-treated sows (87 and 100%, respectively; P = 0.01). Estrus began on average 4.4 ± 1.1 d after the beginning of the follicular phase. In primiparous sows, the interval to estrus was not affected by treatment, but multiparous altrenogest-treated sows had shorter intervals to estrus than did control sows (3.6 ± 0.1 and 4.3 ± 0.2 d, respectively; P = 0.001; Table  2 ). In primiparous sows, estrus tended to be more synchronized (percentage of sows in estrus within a 48-h period) in the RU0-20 (88%) and RU20-20 (89%) treatments compared with the RU40-20 (78%) and control (63%; P = 0.1; Figure 2a ) treatments. In multiparous sows, synchrony of estrus was not affected by treatment (Figure 2b ). The duration of estrus was similar among treatments and lasted on average 63 ± 13 h, but was Table 1 . Follicle size (mm; least squares means ± SE) for sows in the control, RU0-20, RU40-20, and RU20-20 treatments and for primiparous or multiparous sows shorter in primiparous sows than in multiparous sows (59 ± 2 and 65 ± 1 h, respectively; P = 0.007; Table 2 ).
Farrowing rate was on average 87% and was not affected by treatment or parity (Table 2) . In primiparous sows, litter size averaged 12.3 ± 2.5 piglets (born alive + dead), and altrenogest-treated sows had on average 0.9 more piglets per litter than did control sows, although this increase failed to reach significance (P = 0.16; Table 2 ). However, when mummies were included in litter size, primiparous altrenogest-treated sows had larger litters than did primiparous control sows (13.4 ± 0.5 and 11.9 ± 0.7 piglets, respectively; P = 0.02). In contrast, in multiparous sows, treatment did not affect litter size (13.2 ± 0.4 and 13.7 ± 0.6 piglets for altrenogest-treated sows and control sows, respectively). Total litter weight was not affected by treatment, and primiparous sows had a lighter litter weight than did multiparous sows (P < 0.0001; Table 2 ).
Backfat Depth at Weaning and Litter Size
In primiparous sows, an interaction was found between treatment and backfat depth at weaning (P = 0.02; Figure 3a) for litter size. Control sows with a greater backfat depth at weaning had a larger litter size (regression line, y = 0.82x + 0.13; P = 0.05), which was not the case in altrenogest-treated sows (regression line, y = 0.22x + 9.6; P = 0.6). In multiparous sows, backfat at weaning was not related to subsequent litter size (Figure 3b ).
DISCUSSION
In an earlier study (van Leeuwen et al., 2011) , we demonstrated that short-term altrenogest treatments after weaning have beneficial effects on reproductive performance only when small follicles are present on the ovaries at weaning. Therefore, in this study, an attempt was made to prevent the growth of follicles into larger size categories during the last days of lactation by using altrenogest treatments before weaning, and to study subsequent fertility after a postweaning altrenogest treatment. In this study, follicle size increased similarly before weaning in control sows and altrenogest-treated sows, resulting in a similar average follicle size at weaning of 4.0 mm. Follicles become fully LH dependent between 2 to 4 mm (Liu et al., 2000) , and it was expected that the synergistic suppressive effects of lactation and altrenogest administration on LH release would stop the growth of the LH-dependent follicles and possibly induce atresia (as happens during inadequate LH pulsatility in lactation; Lucy et al., 2001) . It was surprising, however, that altrenogest administration before weaning did not prevent follicular growth before weaning.
Regardless of the dose, follicle size also increased during the altrenogest treatment after weaning to approximately 5.3 mm at the beginning of the follicular phase, which is similar to the results of previous studies in which follicle size after altrenogest treatment averaged 4.8 mm (van Leeuwen et al., 2010) and 5.3 mm (van Leeuwen et al., 2011) . The effects of progestagen treatment on follicular development have been extensively studied in cattle. During progestagen treatment, the frequency of LH pulses is reduced, which allows for some follicular development to occur, but it prevents further development and ovulation of the dominant follicle in dairy (Burke et al., 1994) and beef (Bo et al., 1995) breeds. Decreased LH pulsatility, as found during progestagen treatment, is not sufficient to sustain continued growth of the dominant follicle, which, as a result, becomes atretic. Therefore, rates of atresia are greater during progestagen treatment (Savio et al., 1993) . A similar situation may be happening during Table 2 . Follicle size (mm), estrus, farrowing rate, and litter size (least squares means ± SE) for control and altrenogest-treated primiparous and multiparous sows 2 Beginning of follicular phase = weaning for control sows and 1 d after the last altrenogest administration for altrenogest-treated sows. 3 Of sows that showed estrus within 10 d. 4 Of sows that showed estrus within 10 d. Effect of parity: 59.2 ± 2 and 64.8 ± 1 (least squares means ± SE) for primiparous and multiparous sows, respectively; P = 0.007. 5 Percentage of sows in estrus within a 48-h period. 6 No. of farrowing sows/No. of inseminated sows × 100%.
altrenogest treatment in sows when LH pulsatility is reduced. The suppressed LH may be great enough to sustain the follicular development of larger follicles up to a size of approximately 5 mm, but may be too small to support final development to preovulatory sizes. The outgrowth of new cohorts of follicles is prevented by inhibin production by the larger follicles. Preliminary results from a recent study in our laboratory indicate that LH pulsatility is fully suppressed for the first 12 h after administration of 20 mg of altrenogest, after which LH pulsatility progressively resumes (van Leeuwen et al., in press ). Thus, once daily altrenogest administration results in inhibition of LH secretion of variable intensity throughout the day. This may explain why LH-dependent follicles may grow and survive until they reach 5 mm in diameter, but may fail to increase further to reach preovulatory sizes.
However, follicle size at weaning did not affect fertility in the present study, which seems to contradict earlier results (van Leeuwen et al., 2011) in which farrowing rates were reduced in sows with large follicles at initiation of an 8-d postweaning altrenogest treatment. The current study was conducted on the same farm, under similar conditions, with animals of the same genetics, and after a similar lactational burden. Sows also had similar follicle sizes at weaning and at the beginning of the follicular phase. It is, therefore, not clear why the effects of follicle size at weaning on fertility after altrenogest treatment were not replicated in the present study.
In primiparous sows, altrenogest-treated sows had larger litters (piglets born alive + piglets born dead + mummified fetuses) than did control sows (13.4 vs. 11.9) . This is in agreement with studies that found improved ovulation rates after postweaning altrenogest treatment (Koutsotheodoros et al., 1998; Patterson et al., 2008). However, Foxcroft et al. (2006) already demonstrated that when ovulation rates exceed uterine capacity, uterine crowding during the fetal stage of pregnancy results in fetal mortality. Indeed, the fact that litter sizes of primiparous, altrenogest-treated sows were not significantly larger after the exclusion of mummies indicates that fetal mortality rate was indeed increased in altrenogest-treated sows. This agrees with the findings of Patterson et al. (2008) , who found that viable embryo numbers decreased between d 30 and 50 of gestation after postweaning altrenogest treatment, specifically in those sows that had an increased ovulation rate. Thus, altrenogest treatments may generate larger litter sizes when uterine capacity is not limiting during the last part of pregnancy.
Primiparous sows are often weaned with a decreased BCS, associated with suboptimal reproductive performance in the subsequent breeding cycle (Morrow et al., 1989; Zak et al., 1997a) . Primiparous sows in this study lost on average 9% of their BW compared with 7% in multiparous sows, also showing that in this study, the lactational burden was greater for primiparous sows. Because BCS at weaning is often related to lactational BW loss (in our study, backfat at weaning was related to lactational BW loss in primiparous sows; results not shown), it is not clear which of the 2 is more limiting for reproductive performance. In this experiment, primiparous control sows with a decreased backfat depth at weaning had a smaller subsequent litter size than did primiparous control sows with a greater backfat depth at weaning, but this effect was absent in sows that received altrenogest treatment. Altrenogest-treated sows were inseminated on average 12 d after weaning, whereas control sows were inseminated on average 5 d after weaning. Hence, the positive effect of altrenogest administration is most likely an effect of the extended recovery period from weaning as provided by altrenogest treatment. This longer postweaning recovery period allows for an improved nutritional status during prefollicular and preovulatory follicular development, which may improve follicle and oocyte quality and thereby increase embryo survival (Zak et al., 1997a,b; Cosgrove, 1998) . Multiparous sows that were treated with altrenogest did not show an increased litter size. This seems to indicate that a recovery period after weaning (during altrenogest treatment) improves reproductive performance only in sows with a compromised body condition at weaning.
In conclusion, the altrenogest treatments before weaning that were used in this study did not prevent an increase in follicle size in the last days before weaning. Altrenogest treatment after weaning resulted in an increased follicle size at the onset of the follicular phase compared with the control animals. Primiparous altrenogest-treated sows overall had larger litters when mummies were included in litter size, but they did not have significantly more piglets (born alive + born dead), probably because of a limited uterine capacity. An increase in litter size was observed for altrenogest-treated primiparous sows (but not multiparous sows) with a reduced backfat depth at weaning. This indicates that the longer recovery period after weaning improved litter size in sows with a compromised body condition after lactation, a more common finding in primiparous sows than in multiparous sows.
